• Escitalopram (Lexapro): Applied Antidepressant Research Work

  2026-06-29

  Escitalopram (Lexapro) stands as a benchmark SSRI for dissecting serotonergic signaling in depression and anxiety models. This article delivers advanced experimental workflows, protocol enhancements, and troubleshooting strategies to maximize reproducibility and insight in antidepressant research.

• Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis

  2026-06-29

  This study develops a novel ferroptosis-related gene signature for hepatocellular carcinoma (HCC) prognosis and identifies atorvastatin as a potential therapeutic agent to induce ferroptosis and inhibit HCC progression. The findings provide a new molecular framework for risk stratification and highlight atorvastatin's mechanistic relevance in ferroptosis-focused cancer research.

• PP 2 (AG 1879): Src Kinase Inhibition in Vascular and Cancer

  2026-06-28

  Discover how PP 2 (AG 1879), a potent Src family kinase inhibitor, empowers advanced studies of cell signaling, cancer biology, and vascular physiology. This article uniquely bridges mechanistic insight from redox signaling to translational research, revealing new assay strategies.

• Steroid-Induced Protoplast Lysis: Mechanisms and Antagonists

  2026-06-27

  Smith and Shay (1965) advanced the mechanistic understanding of synthetic steroid antimicrobial action by leveraging bacterial protoplast models to dissect lytic mechanisms and the effects of chemical antagonists. Their work provided pivotal evidence that direct action on cell membranes underlies steroid-induced lysis, informing future studies on membrane-targeted antibiotics and the rational use of stabilizing agents.

• GSK621: Precision AMPK Agonist Optimizing AML & Metabolic As

  2026-06-26

  GSK621 is a next-generation AMPK agonist that enables high-fidelity modeling of metabolic reprogramming in acute myeloid leukemia and tumor immunology. Its superior potency and selectivity streamline experimental workflows, enhance reproducibility, and unlock advanced applications in apoptosis induction and autophagy promotion—positioning it as an essential tool for cutting-edge translational research.

• Biotin-tyramide (A8011): Protocol Parameters and Workflow QC

  2026-06-26

  Biotin-tyramide (SKU A8011) addresses the challenge of achieving high-resolution, ultrasensitive signal amplification in immunohistochemistry (IHC) and in situ hybridization (ISH) workflows, especially where detection of low-abundance targets is critical. It is not suitable for live-cell applications or workflows requiring aqueous reagent solubility. This reagent is best deployed in fixed tissue or cell protocols using HRP-catalyzed deposition.

• MDM1 Overexpression Enhances p53 Expression and Therapy Sens

  2026-06-25

  This study reveals that MDM1 overexpression in colorectal cancer (CRC) cells promotes p53 expression and increases apoptosis, leading to improved sensitivity to chemoradiotherapy. The findings highlight MDM1 as a potential biomarker for predicting treatment response and provide mechanistic insight into the p53 pathway’s role in CRC therapy.

• Nile Red for Lipid Droplet Staining: Workflow, Use Cases, an

  2026-06-25

  Nile Red (Nile blue oxazone) empowers researchers to quantitatively visualize intracellular lipid droplets and dissect lipid storage dynamics with unmatched sensitivity. This guide delivers actionable protocols, advanced troubleshooting, and practical insights to maximize reproducibility and selectivity in lipid metabolism research.

• circHIF1A/miR-486-5p/GRHL2 Axis Drives LUAD Progression via

  2026-06-24

  This study delineates the role of the circHIF1A/miR-486-5p/GRHL2 regulatory axis in promoting lung adenocarcinoma (LUAD) progression through the induction of macrophage M2 polarization, establishing a critical link between circular RNA-mediated gene regulation and the tumor immune microenvironment. The findings offer new insight into ceRNA mechanisms in LUAD and highlight potential strategies for molecular targeting and prognostic assessment.

• Amorolfine Hydrochloride: Antifungal Mechanism and Research

  2026-06-23

  Amorolfine Hydrochloride is a potent antifungal reagent that disrupts fungal cell membrane synthesis, making it valuable for advanced fungal infection research. Its efficacy and specificity are supported by both biochemical data and recent studies on cell surface integrity and ploidy stress in yeast. The compound's unique solubility profile and stability enable reproducible, high-purity experimental workflows.

• SB 203580: Advanced Applications in p38 MAPK Pathway Dissect

  2026-06-23

  Explore the advanced roles of SB203580 in p38 MAPK signaling pathway research, focusing on novel mechanistic insights and emerging assay strategies. This article uniquely contextualizes SB203580 for neuroinflammatory and multidrug resistance studies, bridging recent molecular findings with optimized experimental workflows.

• WIP1 Modulation of p38 MAPK Reduces Pyroptosis in Sepsis-AKI

  2026-06-22

  This study identifies WIP1 phosphatase as a key regulator that attenuates renal tubular pyroptosis in sepsis-associated acute kidney injury by suppressing p38 MAPK signaling. The findings offer mechanistic insight into inflammatory injury in septic renal pathology and highlight WIP1 as a potential target for intervention.

• Dual Inhibition of Glycolysis and Glutaminolysis in HCC via

  2026-06-22

  This study identifies FOXO3 as a pivotal regulator that simultaneously inhibits glycolysis and glutaminolysis in hepatocellular carcinoma (HCC) by transcriptionally repressing YAP. The work provides a mechanistic basis for metabolic-based interventions in HCC, highlighting the therapeutic potential of targeting the FOXO3/YAP axis.

• Adefovir (GS-0393): Molecular Selectivity and Translational

  2026-06-21

  Explore the molecular selectivity of Adefovir (GS-0393) as an HBV antiviral agent, with in-depth analysis of its DNA polymerase inhibition pathway and translational implications. Gain new insight into assay optimization and clinical relevance beyond current protocol-focused content.

• Bardoxolone Methyl: Advanced Redox Modulation in Cancer Rese

  2026-06-20

  Bardoxolone methyl (CDDO methyl ester) delivers dual modulation of Nrf2 and NF-kB signaling, enabling unparalleled control in oxidative stress and inflammation assays. This article reveals optimized protocols, translational workflows, and troubleshooting strategies to harness its full potential in disease modeling and experimental oncology.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page